Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
Clinical trial NCT02976701 · TERMINATED
Trial details
- NCT number
- NCT02976701
- Sponsor
- Dexa Medica Group
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2023-01-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.